ATRX and central nervous system cancer: Recent work has shown that mutant IDH1 cooperates with ATRX loss in promoting the alternative lengthening of telomere (ALT) phenotype in gliomas, highlighting mechanisms of pathogenic interplay between the two molecular abnormalities31.